189 related articles for article (PubMed ID: 11509866)
1. No influence of prednisolone on IGFBP-3 proteolysis in healthy young men.
Dall R; Wolthers T; Flyvbjerg A; Grøfte T; Sandahl Christiansen J; Jørgensen JO
Horm Res; 2001; 55(2):95-101. PubMed ID: 11509866
[TBL] [Abstract][Full Text] [Related]
2. Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults.
Skjaerbaek C; Frystyk J; Møller J; Christiansen JS; Orskov H
Eur J Endocrinol; 1996 Dec; 135(6):672-7. PubMed ID: 9025711
[TBL] [Abstract][Full Text] [Related]
3. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group.
Dall R; Longobardi S; Ehrnborg C; Keay N; Rosén T; Jørgensen JO; Cuneo RC; Boroujerdi MA; Cittadini A; Napoli R; Christiansen JS; Bengtsson BA; Sacca L; Baxter RC; Basset EE; Sönksen PH
J Clin Endocrinol Metab; 2000 Nov; 85(11):4193-200. PubMed ID: 11095453
[TBL] [Abstract][Full Text] [Related]
4. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
Münzer T; Rosen CJ; Harman SM; Pabst KM; St Clair C; Sorkin JD; Blackman MR
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
[TBL] [Abstract][Full Text] [Related]
5. IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH.
Zhou X; Loke KY; Pillai CC; How HK; Yap HK; Lee KO
Eur J Endocrinol; 2001 Mar; 144(3):237-43. PubMed ID: 11248742
[TBL] [Abstract][Full Text] [Related]
6. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes.
Dall R; Lange KH; Kjaer M; Jørgensen JO; Christiansen JS; Orskov H; Flyvbjerg A
J Clin Endocrinol Metab; 2001 Feb; 86(2):669-74. PubMed ID: 11158029
[TBL] [Abstract][Full Text] [Related]
7. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H
Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
[TBL] [Abstract][Full Text] [Related]
9. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.
Cotterill AM; Mendel P; Holly JM; Timmins AG; Camacho-Hübner C; Hughes SC; Ross RM; Blum WF; Langford RM
Clin Endocrinol (Oxf); 1996 Jan; 44(1):91-101. PubMed ID: 8706300
[TBL] [Abstract][Full Text] [Related]
10. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans.
Olivecrona H; Hilding A; Ekström C; Barle H; Nyberg B; Möller C; Delhanty PJ; Baxter RC; Angelin B; Ekström TJ; Tally M
J Clin Endocrinol Metab; 1999 Feb; 84(2):553-60. PubMed ID: 10022415
[TBL] [Abstract][Full Text] [Related]
11. High levels of 150-kDa insulin-like growth factor binding protein three ternary complex in patients with acromegaly and the effect of pegvisomant-induced serum IGF-I normalization.
Parkinson C; Flyvbjerg A; Trainer PJ
Growth Horm IGF Res; 2004 Feb; 14(1):59-65. PubMed ID: 14700556
[TBL] [Abstract][Full Text] [Related]
12. The effect of submaximal exercise on immuno- and bioassayable IGF-I activity in patients with GH-deficiency and healthy subjects.
Kanaley JA; Frystyk J; Møller N; Dall R; Chen JW; Nielsen SC; Christiansen JS; Jørgensen JO; Flyvbjerg A
Growth Horm IGF Res; 2005 Aug; 15(4):283-90. PubMed ID: 16027018
[TBL] [Abstract][Full Text] [Related]
13. Serum leptin response to the acute and chronic administration of growth hormone (GH) to elderly subjects with GH deficiency.
Gill MS; Toogood AA; Jones J; Clayton PE; Shalet SM
J Clin Endocrinol Metab; 1999 Apr; 84(4):1288-95. PubMed ID: 10199769
[TBL] [Abstract][Full Text] [Related]
14. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
Khorram O; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
[TBL] [Abstract][Full Text] [Related]
15. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
[TBL] [Abstract][Full Text] [Related]
16. Inaccuracy of insulin-like growth factor (IGF) binding protein (IGFBP)-3 assessment in the diagnosis of growth hormone (GH) deficiency from childhood to young adulthood: association to low GH dependency of IGF-II and presence of circulating IGFBP-3 18-kilodalton fragment.
Cianfarani S; Liguori A; Boemi S; Maghnie M; Iughetti L; Wasniewska M; Street ME; Zucchini S; Aimaretti G; Germani D
J Clin Endocrinol Metab; 2005 Nov; 90(11):6028-34. PubMed ID: 16091488
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults.
Laursen T; Gravholt CH; Heickendorff L; Drustrup J; Kappelgaard AM; Jørgensen JO; Christiansen JS
J Clin Endocrinol Metab; 2001 Mar; 86(3):1222-8. PubMed ID: 11238512
[TBL] [Abstract][Full Text] [Related]
18. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A
Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837
[TBL] [Abstract][Full Text] [Related]
19. The effect of growth hormone on bioactive IGF in overweight/obese women.
Dichtel LE; Bjerre M; Schorr M; Bredella MA; Gerweck AV; Russell BM; Frystyk J; Miller KK
Growth Horm IGF Res; 2018 Jun; 40():20-27. PubMed ID: 29679919
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
